Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > dd

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Mar 12, 2022 8:02pm

157 Views

Post# 34509521

RE:dd

Then if you believe what you are saying ... and you believe that is all there is for THTX, sell your shares and go away. There is a completely different narrative if you care to consider it.

-LT

WilliamX wrote: all I see when I do the due diligence is a company slowly dying, destined to be sold off for pennies on the dollar. It has been interesting reading all you self described "smart in the know investors" mocking the market while the stock went ftom $14 to $3. The volume is telling you all you need to know about the future. This is super speculative. 1a was a failure.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project